Kelly Murphy focuses his practice on counseling clients on intellectual property matters and U.S. government contracts and procurement regulations.

  • Advises clients on patent procurement, regulatory compliance, and negotiation of licensing, collaboration, and service agreements for pharmaceutical and technology companies, food and ingredient manufacturers, nonprofits, and academic institutions
  • Assists clients in procuring and enforcing domestic and international patents; conducting due diligence; and rendering legal opinions on patent validity or non-infringement


Practice Areas



Representative Matters

  • Represented pharmaceutical and technology companies with implementing life cycle strategies for approved therapeutics and marketed products, including
    • Procured domestic and international patents
    • Defended against filed oppositions and inter partes reexamination
    • Obtained national patent listings
    • Filed applications for supplemental protection certificates and patent term extensions
    • Negotiated exclusive license agreements, cooperative research and development agreements, and clinical trial agreements 
  • Represented multinational food manufacturer with patent procurement and patent clearances for global launches of new products and reformulations
  • Prosecuted and obtained numerous patents, including:
    • U.S. Patent No. 8,367,628 Amphoteric Liposome Formulations
    • U.S. Patent No. 7,960,544 Useful Indole Compounds
    • U.S. Patent No. 7,807,647 Methods and Compositions for Cancer Therapy
    • U.S. Patent Nos. 7,704,947; 7,772,188; 7,745,409; 7,910,546 8,080,526; 8,101,579; 8,110,553 Methods and Compositions for the Treatment of Gastrointestinal Disorders
    • U.S. Patent No. 7,659,088: Assay for Inositol Phosphorylceramide Synthase Activity
    • U.S. Patent No. 7,498,315: Methods and Compositions for the Inhibition of Gene Expression
    • U.S. Patent No. D595422: Support device for interventional instruments
    • U.S. Patent No. 7,524,827: Methods and Compositions for the Inhibition of Gene Expression
    • U.S. Patent No. D570,532: Light Fixture Lens and Bezel
    • U.S. Patent No. 7,322,722 B2: Light Fixture
    • U.S. Patent No. 7,374,319: Lighted Handle 

Prior Experience

  • Miller, Canfield, Paddock and Stone, P.L.C., Associate, 2007-2008
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, 2005-2007
  • Human Genome Sciences, 2001-2004
  • Invitrogen Corporation, 2000-2001






IAM Patent 1000, Prosecution: DC Metro Area (2023)

LMG Life Sciences 

  • Recognized practitioner for Patent Prosecution - 2020-2022
  • Patent Prosecution Attorney of the Year – 2021 – Shortlisted nominee
  • Recognized for Patent Prosecution

2015 Client Choice Award by the International Law Office

Michigan Super Lawyers, Recognized as a Rising Star, 2009-2014

Professional & Community Involvement

American Bar Association

  • Intellectual Property Law Section 

American Intellectual Property Law Association 

State Bar of Michigan

  • Intellectual Property Law Section 

District of Columbia Bar Association

  • Intellectual Property Law Section 

American Association for the Advancement of Science 

Kalamazoo County Bar Association 

Biotechnology Industry Organization 


Gilmore Keyboard Festival

  • Board of Trustees, 2014-present

Crescendo Academy of Music

  • Board of Directors, 2010-2012

News & Insights


  • Kelly T. Murphy quoted in MiBiz article “Experts: Timing perfect for investment in life science startups”
    Media |


  • Event | Washington, D.C. | | | Presenter
  • Demystifying Government Use Rights: What Funding Recipients Should Know
    Event | San Antonio, TX | February 28-March 2, 2013 | | Moderator and presenter
  • Tech Transfer and Co-Development Partnerships with the NIH
    Event | East Lansing, MI | November 7-8, 2012 | | Moderator
  • America Invents Act Comes to Campus: The Impact on Commercialization and Technology Transfer Offices
    Event | Boston, MA | June 18-21, 2012 | Moderator
  • Emerging Business: Protecting IP – Patent Reform, PTO Changes & Court Decisions
    Event | Grand Rapids, MI | | | Co-presenter
  • Impact of U.S. Patent Reform on Biotechnology
    Event | Grand Rapids, MI | | Presenter
  • Understanding the Other Side of the Table: Perspectives from commercial licensees
    Event | Rockville, MD |
  • IP Protocol for the Central Corridor Licensing Partnership
    Event | Detroit, MI | |
  • Technology Development for Extramural Programs, Division of Acquired Immunodeficiency Syndrome
    Event | Bethesda, MD | |
  • NIAID’s Technology Transfer and Intellectual Property Resources
    Event | Bethesda, MD | |
  • Inhibition of NF-kB Reduces Cellular Proliferation and Foci Formation in Breast Carcinomas and Glioblastomas
    Event | Washington, D.C. | December 11-15, 1999 |


  • The Changing Tide of Patentability Standards and Filing Timelines for Biotechnologies
    Publication | The Impact of Recent Patent Law Cases and Developments, Aspatore: Inside the Minds™ | 2012
  • Lifting the R&D Organizational Veil under the American Recovery Reinvestment Act
    Publication | Michigan Biosciences LINK |
  • Development of a Long-acting Insulin Analog Using Albumin Fusion Technology
    Publication | 54 (1) Diabetes 251-258 |
  • Use of Fluorescently Labeled DNA and a Scanner for Electrophoretic Mobility Shift Assays
    Publication | 30(s) Biotechniques 504-506 |
  • The Role of NF-kB in Breast Carcinoma and Glioblastoma Cell Lines
    Publication | Thesis Publication, Dwight B. Waldo Library, General Stacks, Western Michigan University, Department of Biological Sciences |
Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.